Today, Great Bay Bio (GBB) announced an expanded strategic partnership with Chime Biologics, a global leader in CDMO.

Today, Great Bay Bio (GBB) announced an expanded strategic partnership with Chime Biologics, a global leader in CDMO.

Recently, Great Bay Bio (GBB) partnered with Professor JZ Chen from the Koch Institute for Integrative Cancer Research

Great Bay Bio self-developed AI-enabled cell culture media, AlfaMedX (NF3370+DF2025), leverages cutting-edge technologies, including AI, to analyze and predict large volumes of experimental data. This approach optimizes the composition and usage condition

The Guangdong-Hong Kong-Macao Greater Bay Area Biotech Innovation Summit and the 7th Top 50 Innovative Biotech Compani

Hong Kong December 16, 2024 Great Bay Bio (GBB) is thrilled to announce the successful first close of its Series B

The AlfaMedX platform applies AI technology to the development of cell culture media formulations, establishing a media formulation algorithm platform to develop media suitable for cell growth, protein expression, and cell differentiation, including basal

Hong Kong November 7, 2024                          D